Stay updated on Safety Tolerability in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability in IPF Clinical Trial page.

Latest updates to the Safety Tolerability in IPF Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe clinical trial record for MN-001 (tipelukast) in idiopathic pulmonary fibrosis is available, with study design, participant eligibility, outcome measures, results, dates, and linked protocol documents.SummaryDifference51%

- Check20 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error rather than study information.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide banner announces a transition in NIH terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1 on the error page.SummaryDifference0.2%

- Check61 days agoChange DetectedA 403 Forbidden error page is displayed for the study entry, replacing the normal study record content. This indicates restricted access to the page.SummaryDifference19%

Stay in the know with updates to Safety Tolerability in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability in IPF Clinical Trial page.